HRTX FY 2007 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$147M

FY 2007 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$412,000-92.4% YoY

Gross Profit

$412,000100.0% margin

Operating Income

-$24M-5736.2% margin

Net Income

-$20M-4893.9% margin

EPS (Diluted)

$-20.80

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$37M

Total Liabilities

$7M

Stockholders' Equity

$29M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$412,000	$5M	-92.4%
Gross Profit	$412,000	$0	—
Operating Income	-$24M	-$19M	-25.3%
Net Income	-$20M	$5M	-482.9%